Nick Paul TaylorMolecular DiagnosticsWidespread resistance to last-resort antibiotic spurs development of new assayScientists in Germany are developing an assay to detect resistance levels and thereby reduce the frequency of therapeutic failures when using colistin to treat infections with Enterobacter.January 30, 2023COVID-19Study: One-third of ‘mostly young and healthy’ people develop long COVID symptomsThe severity of the initial acute infection significantly correlated to the risk of long COVID.January 27, 2023Rare DiseaseDNA tests show that mystery inflammatory syndrome may not be so rarePhysicians need to add VEXAS syndrome to the list of potential diagnoses when they see patients with persistent and unexplained inflammation and low blood cell counts, or anemia, the lead investigator of a new study said.January 24, 2023COVID-19Risk of death remains elevated for at least 18 months after COVID-19 infection: StudyBy analyzing patient samples in the UK Biobank, a large biomedical database, researchers sought to show if there are long-term associations between COVID-19, cardiovascular disease, and mortality.January 19, 2023Molecular DiagnosticsNewborn screening for neuromuscular disorder leads to improved outcomes in Australian studySeeing a lack of real-world evidence on the impact of newborn spinal muscular atrophy screening, researchers at Sydney Children’s Hospital Network in Australia ran a prospective study to evaluate its potential.January 18, 2023COVID-19Study finds most long COVID symptoms resolve within one year of infectionThe study looked at data on two million members of an Israeli public health organization who were tested for COVID-19 between March 2020 and October 2021. Most symptoms seen in the 180 days after infection resolved over the following 180 days.January 12, 2023CollaborationBlood test could improve detection of potentially fatal pregnancy complication: studyResearchers ran a nested case-control study of 35 cases and 70 controls to find circulating microparticle protein panels that identify pregnancies complicated by placenta accreta spectrum.January 9, 2023Gene silencing and gene editingDiscovery of destructive CRISPR enzyme opens up diagnostic, therapeutic applications for molecular scissorsIn a pair of Nature papers, researchers describe the structure and function of Cas12a2, which binds and cuts target DNA to shut off a specific gene so that the enzymes can be used as molecular scissors.January 4, 2023Page 1 of 1Top StoriesPathology and AI3D spatial maps characterize biology enabling tumor growth: NIH directorIn an NIH-sponsored study, researchers used cyclic immunofluorescence to obtain many rounds of highly detailed molecular imaging on each tissue sample and provided molecular data, cell by cell.Point-of-Care TestingJana Care, Roche to develop blood-testing platform for chronic kidney and heart diseaseTechnology DevelopmentDuke University developing blood test to detect osteoarthritis progression in the kneeCOVID-19COVID-19 immune response strengthens over time: StudyBreast CancerGuardant360 CDx breast cancer liquid biopsy test receives FDA approval as companion diagnostic
